NEW YORK (TheStreet) -- CHANGE IN RATINGS
Biomarin (BMRN) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Risk/reward is no longer compelling at current levels. $45 price target.
Energy Partners (BKEP) downgraded to sell at TheStreet Ratings.
Chiquita Brands (CQB) downgraded to sell at TheStreet Ratings.Globus Medical (GMED) rated new Outperform at William Blair. Company can gain market share and deliver above-average annual sales growth. LyondellBasell (LYB) downgraded at UBS from Buy to Neutral, UBS said. $49 price target. Company could be hurt by rising ethane prices. Public Service (PEG) downgraded at FBR to Underperform, FBR Capital Markets said. Valuation call, based on a $30 price target. Treehouse (THS) upgraded at Citigroup from Neutral to Buy, Citigroup said. $61 price target. Estimates also boosted, ahead of the private-label K-Cup launch. Westlake Chemical (WLK) downgraded at UBS from Neutral to Sell, UBS said. Valuation call, based on a $54 price target. Weyerhaeuser (WY) upgraded at BMO from Underperform to Market Perform, BMO Capital said. Company is leveraged to rising lumber and panel prices. $26.50 price target.
STOCK COMMENTS / EPS CHANGESApple (AAPL) target raised at Oppenheimer to $800, according to Oppenheimer. Expect higher mini-iPad and iPhone sales. Outperform rating. Advanced Micro (AMD) numbers reduced at Sterne Agee. Shares of AMD now seen reaching $6, according to Sterne Agee. Estimates also cut, given weaker consumer demand. Neutral rating. Groupon (GRPN) target reduced at Ascendiant to $3.50. Growth uncertainties and concerns remain. Sell rating. Intel (INTC) estimates reduced at JMP through 2013, JMP Securities said. Industry checks suggest weaker PC demand. Outperform rating and $33 price target. Intel estimates, target cut at Citigroup. INTC estimates were reduced through 2013, Citigroup said. Company is likely to fall short of near-term earnings expectations. Buy rating and new $32 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV